Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Intensive BP Lowering May Not Reduce Risk of Recurrent Stroke

Publish date:: April 16, 2019

Key clinical point: Compared with standard treatment, intensive blood pressure reduction provides a nonsignificant reduction of recurrent stroke risk.

Major finding: The rate of recurrent stroke was 1.65% in the intensive treatment group and 2.26% in the standard treatment group.

Study details: A randomized, open-label trial of 1,263 patients with a history of stroke in the previous 3 years.

Disclosures: This study was sponsored by Biomedis International.

Citation:

Kitagawa K et al. ISC 2019, Abstract LB10.

This Week's Must Reads

Biomarkers Support Impact of Concussions on Cognitive Function,

Is Professional Soccer a Risk Factor for ALS?,

Perplexing Text Messages May be the Sole Sign of Stroke,

SLE Prevalence Jumped 60% in a Decade in US,

Bundled Payment for OA Surgery Means More Emergency Department Visits,

Must Reads in Cardiology

Ankylosing Spondylitis Patients Taking COX-2 Inhibitors May See Fewer CV Events,

BMI in Male Teens Predicts Cardiomyopathy Risk,

Poor Response to Statins Increases Risk of CV Events,

Intensive BP Lowering May Not Reduce Risk of Recurrent Stroke,

MI Alert Device Has Predictive Value,